In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents
- PMID: 2387294
- DOI: 10.1007/BF01979472
In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents
Abstract
In vitro testing of the activity of 15 antibacterial agents against 522 clinical isolates of Aeromonas species demonstrated some species-associated trends. Amoxicillin plus clavulanic acid was effective against approximately 45% of Aeromonas caviae and Aeromonas hydrophila, but all Aeromonas sobria isolates were resistant. Aztreonam, piperacillin and mezlocillin were highly active against all the strains of Aeromonas tested. Ticarcillin was equally effective against Aeromonas caviae and Aeromonas hydrophila, but more than 50% of Aeromonas sobria isolates were resistant. The latter species was more susceptible to cephalosporins than Aeromonas hydrophila and Aeromonas caviae. Chloramphenicol, tetracycline and trimethoprim-sulfamethoxazole were extremely active against all three Aeromonas species, likewise ofloxacin and ciprofloxacin. Aztreonam, third-generation cephalosporins, chloramphenicol and the quinolones can thus be considered for therapy of infections when Aeromonas is implicated.
Similar articles
-
Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):248-50. doi: 10.1007/BF01965270. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2496995
-
In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.Antimicrob Agents Chemother. 1985 Jul;28(1):151-3. doi: 10.1128/AAC.28.1.151. Antimicrob Agents Chemother. 1985. PMID: 4037775 Free PMC article.
-
Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria.Int Microbiol. 2010 Sep;13(3):135-41. doi: 10.2436/20.1501.01.118. Int Microbiol. 2010. PMID: 20890847
-
Septic arthritis due to Aeromonas hydrophila: case report and review of the literature.Int J Clin Pract Suppl. 2005 Apr;(147):121-4. doi: 10.1111/j.1368-504x.2005.00338.x. Int J Clin Pract Suppl. 2005. PMID: 15875648 Review.
-
Aeromonas spp.: An Emerging Nosocomial Pathogen.J Lab Physicians. 2016 Jan-Jun;8(1):1-4. doi: 10.4103/0974-2727.176234. J Lab Physicians. 2016. PMID: 27013806 Free PMC article. Review.
Cited by
-
Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2369-77. doi: 10.1007/s10096-012-1578-x. Epub 2012 Feb 27. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22367351
-
In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.Antimicrob Agents Chemother. 1993 Apr;37(4):905-7. doi: 10.1128/AAC.37.4.905. Antimicrob Agents Chemother. 1993. PMID: 8494389 Free PMC article.
-
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.Antimicrob Agents Chemother. 2003 Jul;47(7):2217-22. doi: 10.1128/AAC.47.7.2217-2222.2003. Antimicrob Agents Chemother. 2003. PMID: 12821471 Free PMC article.
-
Occurrence of antimicrobial resistance in fish-pathogenic and environmental bacteria associated with four danish rainbow trout farms.Appl Environ Microbiol. 2000 Nov;66(11):4908-15. doi: 10.1128/AEM.66.11.4908-4915.2000. Appl Environ Microbiol. 2000. PMID: 11055942 Free PMC article.
-
Septicemia due to Aeromonas hydrophila in a pregnant woman: a case report and review of the literature.Infect Dis Obstet Gynecol. 1995;3(6):252-5. doi: 10.1155/S1064744995000743. Infect Dis Obstet Gynecol. 1995. PMID: 18476052 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical